In a letter to R Nicholson (Immuno), M E Duncan (DHSS) confirmed that the Licensing Authority encouraged pharmaceutical companies to use a dry heat treatment process.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr Mary E Duncan
R Nicholson